Chronic kidney disease. Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
Conditions
Interventions
Intervention 1: The intervention group1:They will give 4000 units of erythropoietin three times a week for two consecutive months in subcutaneous form. At the end of each month, the hematocrit and h
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Have Chronic kidney disease Hemodialysis is performed three times a week Recieving Erythropoietin three times in a week The patients are within the age limit of 18 - 60
Exclusion criteria
Exclusion criteria: Suffering from Cardiovascular disease Recently, he has had acute bleeding. Severe infection Not satisfied with participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematocrit. Timepoint: Measurement of hematocrit levels at the end of the first month and the second month in both methods. Method of measurement: Siys max device.;Hemoglobin. Timepoint: Measurement of Hemoglobin levels at the end of the first month and the second month in both methods. Method of measurement: Siys max device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients Satisfaction. Timepoint: after tow month of intervention. Method of measurement: Satisfaction Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Reza Mazloum
Mashhad University of Medical Sciences
Outcome results
None listed